BioDelivery Sciences International Inc.


Company Update (NASDAQ:BDSI): Why BioDelivery Sciences International, Inc. Shares Are on the Ropes Today

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) and Endo International (NASDAQ:ENDP) announced this morning that Clonidine Topical Gel failed to meet its primary endpoint in …

BioDelivery Sciences International, Inc. (BDSI) Shares Open Higher on Back of Top Analyst Upgrade

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares are up 13% this morning, after Janney Montgomery analyst Ken Trbovich upgraded BDSI from a Neutral to a Buy rating …

Roth Capital Analysts Cut Price Targets for Galena Biopharma Inc (GALE) and BioDelivery Sciences International, Inc. (BDSI) But Remain Positive

Roth Capital analysts weighed in on Galena Biopharma Inc (NASDAQ:GALE) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) following Q4:15 earnings from both companies.

Biotech Roundup: Celldex Therapeutics, Inc. (CLDX), Keryx Biopharmaceuticals (KERX), BioDelivery Sciences International, Inc. (BDSI)

Biotech stocks are notoriously volatile as a pipeline update or FDA announcement can instantly send share prices through the roof. Below, analysts weigh …

Biotech Beat: Analysts Bullish On Relypsa Inc (RLYP) And BioDelivery Sciences International, Inc. (BDSI)

Healthcare analysts provided insight on both Relypsa Inc (NASDAQ:RLYP) and BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with bullish outlooks.

Roth Capital Weighs In on BioDelivery Sciences International, Inc. (BDSI) Following Bunavail Supply Glitch

Roth Capital analyst Scott Henry weighed in today with his views on BioDelivery Sciences International, Inc.(NASDAQ:BDSI), after the company announced a supply constraint for its opioid dependence product …

DHHS to Expand Opioid Dependence Class; Additional Tailwind For BioDelivery Sciences’ Bunavail, Says William Blair

In a research report issued Friday, William Blair analyst Tim Lugo reiterated a Buy rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with …

William Blair Reiterates Upbeat View Of BioDelivery Sciences International, Inc. Following Exclusive TennCare Agreement

In a research report released Tuesday, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) with a …

Janney Montgomery Pounds The Table On BioDelivery Sciences International, Inc. (BDSI)

Janney Montgomery’s healthcare analyst Chiara Russo was out pounding the table on BioDelivery Sciences International, Inc. (NASDAQ:BDSI), reiterating a Buy rating and price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts